Jeffery Graves, MD
Dermatology · Overland Park, KSNPI 1295994895
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.9% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 29.9% of the total.
Across 92 payments — averaging $37.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$282
- Novartis$276
- Regeneron Healthcare Solutions, Inc.$223
- Pfizer$207
- E.r. Squibb & Sons, L.L.C.$166
- plus $1K from 13 others
What the payments were for
- Speaking & faculty fees$2086%
- Food & beverage$3,14091%
- Education$1063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 46 | $1,032 |
| Lilly USA, LLC | 3 | $282 |
| Novartis | 10 | $276 |
| Regeneron Healthcare Solutions, Inc. | 2 | $223 |
| Pfizer | 2 | $207 |
| E.r. Squibb & Sons, L.L.C. | 6 | $166 |
| Sun Pharmaceutical Industries Inc. | 3 | $157 |
| UCB, Inc. | 2 | $155 |
| Johnson & Johnson | 4 | $152 |
| Roche Diagnostics Corporation | 1 | $148 |
| Bristol Myers Squibb | 2 | $127 |
| Arcutis Biotherapeutics, Inc. | 1 | $111 |
| Incyte Corporation | 1 | $106 |
| Almirall LLC | 1 | $86 |
| Dermavant Sciences, Inc. | 1 | $70 |
| Stemline Therapeutics Inc. | 1 | $65 |
| Galderma Laboratories, L.p. | 3 | $43 |
| LEO Pharma Inc. | 2 | $36 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,454 in reported general payments places this provider in the 65th percentile of 82 dermatology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 107 | $6,247 |
| Clobetasol Propionate | 63 | $3,296 |
| Ketoconazole | 174 | $2,520 |
| Doxycycline Hyclate | 67 | $1,546 |
| Triamcinolone Acetonide | 115 | $1,478 |
| Mometasone Furoate | 100 | $1,340 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 34 | $1,222 |
| Clindamycin Phosphate | 26 | $1,180 |
| Metronidazole | 22 | $1,044 |
| Spironolactone | 13 | $337 |
| ValacyclovirValacyclovir Hcl | 12 | $231 |
| Mupirocin | 25 | $142 |
| Fluconazole | 26 | $122 |
| Prednisone | 22 | $47 |
| Cephalexin | 12 | $14 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Overland Park
- David KaplanOverland Park$489K
- Meena SinghOverland Park$181K
- Reba SuriOverland Park$7K
- Lauren Kyle TkachukOverland Park$6K
- Megan LentOverland Park$5K
- Mark McCuneOverland Park$5K
- Carol FouldsOverland Park$3K
- Stephen MatlockOverland Park$3K
- Mitchell GibbonsOverland Park$2K
- Lisa MorrisOverland Park$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.